Cognitive
Semax
A synthetic heptapeptide analog of ACTH(4-10) developed at the Institute of Molecular Genetics, Russian Academy of Sciences. Semax is one of the most extensively studied nootropic peptides in Russian pharmacological research.
Molecular Specifications
Mechanism of Action
How It Works
Research has examined Semax's effects on BDNF expression, NGF modulation, and monoamine neurotransmitter systems. Studies have investigated its interaction with melanocortin receptors and downstream signaling cascades in neural tissue models.
Published Research
Research Summary
Published literature includes studies on cognitive function, neuroprotection, and cerebrovascular models, primarily from Russian research institutions. Semax has regulatory approval in Russia as a prescription medication for specific neurological indications — this does not constitute approval in any other jurisdiction.
Research Use Only
The information on this page is for educational and research purposes only. It is based on published preclinical and in-vitro studies. This compound is sold for laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, mitigate, or prevent any disease.
Available Sizes